PAK1 as a Potential Therapeutic Target in Male Smokers with EGFR-Mutant Non-Small Cell Lung Cancer
P21-activated kinases (PAKs) are serine/threonine protein kinases that contribute to several cellular processes. Here, we aimed to determine the prognostic value of PAK1 and its correlation with the clinicopathological characteristics and five-year survival rates in patients with non-small cell lung...
Main Authors: | Jae Heun Chung, Taehwa Kim, Yong Jung Kang, Seong Hoon Yoon, Yun Seong Kim, Sung Kwang Lee, Joo Hyung Son, Bongsoo Son, Do Hyung Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/23/5588 |
Similar Items
-
Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor
by: Xie Y, et al.
Published: (2021-10-01) -
Predicting the risk of chronic bronchitis in teenage smokers
by: S.I. Ilchenko, et al.
Published: (2017-05-01) -
Polonium in bronchial washing specimens of smoker, ex-smoker and non-smoker patients with lung cancer
by: Maria Sofia Cattaruzza, et al.
Published: (2019-03-01) -
Comparison of respiratory muscle strength between cigarettes smokers, second-hand smokers and non-cigarettes smokers
by: Kanokthip Sawangjaithum, et al.
Published: (2017-01-01) -
Osteopontin in chronic obstructive pulmonary disease: Smokers and ex-smokers
by: Ahmed A Ali, et al.
Published: (2015-01-01)